A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the … SS Lim, T Vos, AD Flaxman, G Danaei, K Shibuya, H Adair-Rohani, ... The lancet 380 (9859), 2224-2260, 2012 | 15870 | 2012 |
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11559 | 2012 |
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10579 | 2012 |
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4170* | 2020 |
Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 3312 | 2017 |
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors CJL Murray, J Abraham, MK Ali, M Alvarado, C Atkinson, LM Baddour, ... Jama 310 (6), 591-606, 2013 | 3221 | 2013 |
National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys MN Mascarenhas, SR Flaxman, T Boerma, S Vanderpoel, GA Stevens PLoS medicine 9 (12), e1001356, 2012 | 3157 | 2012 |
European Union Regulations on Algorithmic Decision-Making and a “Right to Explanation” B Goodman, S Flaxman AI Magazine 38 (3), 2017 | 2691 | 2017 |
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 2591 | 2017 |
A systematic analysis of global anemia burden from 1990 to 2010 NJ Kassebaum, R Jasrasaria, M Naghavi, SK Wulf, N Johns, R Lozano, ... Blood, the Journal of the American Society of Hematology 123 (5), 615-624, 2014 | 2523 | 2014 |
Filter bubbles, echo chambers, and online news consumption S Flaxman, S Goel, JM Rao Public opinion quarterly 80 (S1), 298-320, 2016 | 2511 | 2016 |
Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a … GA Stevens, MM Finucane, LM De-Regil, CJ Paciorek, SR Flaxman, ... The Lancet Global Health 1 (1), e16-e25, 2013 | 2396 | 2013 |
Causes of vision loss worldwide, 1990–2010: a systematic analysis RRA Bourne, GA Stevens, RA White, JL Smith, SR Flaxman, H Price, ... The lancet global health 1 (6), e339-e349, 2013 | 2236 | 2013 |
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1731* | 2021 |
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ... Science 372 (6544), 815-821, 2021 | 1634 | 2021 |
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1559 | 2021 |
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1276 | 2021 |
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022 | 1204 | 2022 |
Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries G Stevens, S Flaxman, E Brunskill, M Mascarenhas, CD Mathers, ... The European Journal of Public Health 23 (1), 146-152, 2013 | 863 | 2013 |
Detecting and quantifying causal associations in large nonlinear time series datasets J Runge, P Nowack, M Kretschmer, S Flaxman, D Sejdinovic Science advances 5 (11), eaau4996, 2019 | 791 | 2019 |